APA (7th ed.) Citation

Mircetic, J., Camgöz, A., Abohawya, M., Ding, L., Dietzel, J., Tobar, S. G., . . . Stange, D. E. (2023). CRISPR/Cas9 Screen in Gastric Cancer Patient‐Derived Organoids Reveals KDM1A‐NDRG1 Axis as a Targetable Vulnerability. Small Methods, 7(6), 1. https://doi.org/10.1002/smtd.202201605

Chicago Style (17th ed.) Citation

Mircetic, Jovan, et al. "CRISPR/Cas9 Screen in Gastric Cancer Patient‐Derived Organoids Reveals KDM1A‐NDRG1 Axis as a Targetable Vulnerability." Small Methods 7, no. 6 (2023): 1. https://doi.org/10.1002/smtd.202201605.

MLA (9th ed.) Citation

Mircetic, Jovan, et al. "CRISPR/Cas9 Screen in Gastric Cancer Patient‐Derived Organoids Reveals KDM1A‐NDRG1 Axis as a Targetable Vulnerability." Small Methods, vol. 7, no. 6, 2023, p. 1, https://doi.org/10.1002/smtd.202201605.